Analysed CRISPR THERAPEUTICS AG (CRSP:NASDAQ) News Sources
Eli Lilly Just Proved Gene Editing Could Be Pharma's Next Gold Rush -- but CRISPR Therapeutics Investors Should Watch Out
03-06-2026
fool.com
[Latest] Global CRISPR-based Gene Editing Market Size/Share Worth USD 12.6 Billion by 2034 at a 13.01% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
03-06-2026
yahoo.com
CRISPR Therapeutics Stock Is Absurdly Cheap -- Here's Why Analysts See 437% Upside Potential
03-06-2026
fool.com
CRISPR Therapeutics AG (CRSP): One of The most Shorted Mid Cap Stocks to Buy on Robust Gene Editing Pipeline
06-06-2026
yahoo.com
CRISPR Therapeutics Has $2.4 Billion in Cash and an Approved Drug. Why Is Its Stock Trading Nearly 40% Below the Wall Street Consensus?
08-06-2026
fool.com
CRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to Know
10-06-2026
yahoo.com
What is the current price of CRISPR THERAPEUTICS AG (CRSP:NASDAQ)?
The current price of CRISPR THERAPEUTICS AG (CRSP:NASDAQ) is $49.81.
CRISPR THERAPEUTICS AG (CRSP:NASDAQ) absolute price change since previous trading day?
The absolute price change of CRISPR THERAPEUTICS AG (CRSP:NASDAQ) since the previous trading day is $-0.42.
CRISPR THERAPEUTICS AG (CRSP:NASDAQ) percentage price change since previous trading day?
The percentage price change of CRISPR THERAPEUTICS AG (CRSP:NASDAQ) since the previous trading day is -0.8362%.
What is the most recent average sentiment score for CRISPR THERAPEUTICS AG (CRSP:NASDAQ)?
The most recent average sentiment score for CRISPR THERAPEUTICS AG (CRSP:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for CRISPR THERAPEUTICS AG (CRSP:NASDAQ)?
The most recent sentiment for CRISPR THERAPEUTICS AG (CRSP:NASDAQ) is .
SEC-8K** Filing Available For CRISPR THERAPEUTICS AG (CRSP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.